Frontiers in Pharmacology Impact Factor 2025

Key Takeaways

• Frontiers in Pharmacology holds a 5.4 Impact Factor for 2025, placing it in the Q1 quartile in Pharmacology & Pharmacy.
• Published by Frontiers Media SA (Switzerland), this open-access journal operates on a continuous publication model.
• The journal covers drug discovery, clinical pharmacology, pharmacogenomics, neuropharmacology, cardiovascular pharmacology, ethnopharmacology, pharmacokinetics, toxicology.
• It has accumulated 133,302 total citations in the Web of Science database.
• Indexed in SCIE, PubMed Central, and Scopus with an H-index of 118.

Frontiers in Pharmacology is an open-access journal publishing research spanning all aspects of pharmacology including drug discovery, clinical pharmacology, pharmacogenomics, neuropharmacology, and cardiovascular pharmacology. The journal publishes rigorously peer-reviewed research spanning all aspects of pharmacology, from drug discovery and development to clinical pharmacology, pharmacogenomics, neuropharmacology, cardiovascular pharmacology, and ethnopharmacology. Established in 2014 as part of the Frontiers publishing ecosystem, it has grown into one of the leading venues for disseminating pharmacology research findings globally.

OVERVIEWAbout Frontiers in Pharmacology Journal

Operating under the Frontiers Media platform, Frontiers in Pharmacology employs a collaborative peer-review model where editorial decisions involve both independent reviewers and academic editors. This approach aims to balance rigor with efficiency, reducing time-to-publication while maintaining scientific standards. The journal’s editorial board includes specialists from leading research institutions across North America, Europe, and Asia.

IMPACT FACTORFrontiers in Pharmacology Impact Factor

According to the 2025 Journal Citation Reports (Clarivate), Frontiers in Pharmacology has earned an Impact Factor of 5.4, positioning it in Q1 within the Pharmacology & Pharmacy category. The Impact Factor reflects the ratio of citations received in 2025 to citable items published in 2023 and 2024.

The journal’s citation trajectory reflects its standing within the Pharmacology & Pharmacy research community. With 133,302 total citations recorded in the Web of Science Core Collection, it ranks among the actively cited journals in its discipline. The Q1 quartile placement confirms competitive positioning relative to peer journals in the same category.

METRICSFrontiers in Pharmacology Journal Metrics

Beyond the Journal Impact Factor, Frontiers in Pharmacology is evaluated through several bibliometric indicators that together provide a rounded view of its scholarly influence:

CiteScore measures average citations per document over a four-year window, while SNIP (Source Normalized Impact per Paper) adjusts for field-specific citation practices. SJR (SCImago Journal Rank) weights citations by the prestige of the citing journal. Together, these metrics confirm Frontiers in Pharmacology as a well-cited venue in Pharmacology & Pharmacy.

SCOPEFrontiers in Pharmacology Aim and Scope

The journal welcomes original research articles, systematic reviews, meta-analyses, methods papers, brief reports, and opinion pieces across its specialty sections. Core coverage areas include drug discovery, clinical pharmacology, pharmacogenomics, neuropharmacology, cardiovascular pharmacology, ethnopharmacology, pharmacokinetics, toxicology. Interdisciplinary submissions connecting pharmacology research with computational biology, clinical medicine, or public health are particularly encouraged.

Section editors oversee manuscript evaluation within their domains, ensuring that accepted papers meet both disciplinary standards and broader methodological requirements. The journal also publishes registered reports and protocol papers, supporting reproducibility in pharmacology research.

SUBMISSIONSubmission Process

Authors must submit manuscripts through the Frontiers online editorial system. Initial screening checks for scope alignment, plagiarism, and formatting compliance before assignment to an academic editor. The collaborative peer review typically involves at least two independent reviewers per manuscript.

Accepted articles are published under open-access licenses (CC-BY), making them immediately available to the global research community. Article Processing Charges (APCs) apply and vary by article type; waivers are available for authors from low-income countries upon request.

FAQFrequently Asked Questions